PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF MITOXANTRONE GIVEN TO PATIENTS BY INTRAPERITONEAL ADMINISTRATION

被引：0
|
作者：
ALBERTS, DS
SURWIT, EA
PENG, YM
MCCLOSKEY, T
RIVEST, R
GRAHAM, V
MCDONALD, L
ROE, D
机构：
[1] UNIV ARIZONA,COLL MED,DEPT PHARMACOL,TUCSON,AZ 85724
[2] UNIV ARIZONA,COLL MED,DEPT OBSTET & GYNECOL,TUCSON,AZ 85724
[3] UNIV ARIZONA,ARIZONA CANC CTR,PHARMACOL RES PROGRAM,TUCSON,AZ 85724
[4] AMER CYANAMID CO,MED RES DIV,PEARL RIVER,NY 10965
来源：
CANCER RESEARCH | 1988年 / 48卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5874 / 5877
页数：4
相关论文
共 50 条
  • [1] PHASE-I STUDY OF INTRAPERITONEAL MITOXANTRONE CLINICAL AND PHARMACOKINETIC EVALUATION
    BLOCHLDAUM, B
    EICHLER, HG
    RAINER, H
    JAKESZ, R
    SALZER, H
    STEGER, G
    SCHULLER, J
    GUNTHER, E
    PROKSCH, P
    EHNINGER, G
    ONKOLOGIE, 1987, 10 (01): : 54 - 56
  • [2] ESCALATING DOSE REGIMEN OF INTRAPERITONEAL MITOXANTRONE - PHASE-I STUDY - CLINICAL AND PHARMACOKINETIC EVALUATION
    BLOCHLDAUM, B
    EICHLER, HG
    RAINER, H
    JAKESZ, R
    SALZER, H
    STEGER, G
    SCHULLER, J
    GUNTHER, E
    PROKSCH, B
    EHNINGER, G
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (07): : 1133 - 1138
  • [3] TENIPOSIDE AND CISPLATIN GIVEN BY INTRAPERITONEAL ADMINISTRATION - PRECLINICAL AND PHASE-I PHARMACOKINETIC STUDIES
    CHATELUT, E
    DEFORNI, M
    CANAL, P
    CHEVREAU, C
    ROCHE, H
    PLUSQUELLEC, Y
    JOHNSON, NP
    HOUIN, G
    BUGAT, R
    ANNALS OF ONCOLOGY, 1991, 2 (03) : 217 - 221
  • [4] PHASE-I AND PHARMACOKINETIC STUDY OF INTRAPERITONEAL ORMAPLATIN
    PLAXE, SC
    BRALY, PS
    FREDDO, JL
    MCCLAY, E
    CHRISTEN, RD
    KIRMANI, S
    KIM, S
    HEATH, D
    HOWELL, SB
    GYNECOLOGIC ONCOLOGY, 1993, 51 (01) : 72 - 77
  • [5] PHASE-I PHARMACOKINETIC STUDY OF INTRAPERITONEAL ETOPOSIDE
    ODWYER, PJ
    LACRETA, FP
    DAUGHERTY, JP
    HOGAN, M
    ROSENBLUM, NG
    ODWYER, JL
    COMIS, RL
    CANCER RESEARCH, 1991, 51 (08) : 2041 - 2046
  • [6] A PHASE-I AND PHARMACOKINETIC STUDY OF INTRAPERITONEAL CARBOPLATIN AND ETOPOSIDE
    MCCLAY, EF
    GOEL, R
    ANDREWS, P
    GORELICK, S
    KIRMANI, S
    KIM, S
    BRALY, P
    PLAXE, S
    HOFF, S
    ALCARAZ, J
    HOWELL, SB
    BRITISH JOURNAL OF CANCER, 1993, 68 (04) : 783 - 788
  • [7] PHASE-I PHARMACOKINETIC STUDY OF INTRAPERITONEAL CISPLATIN AND ETOPOSIDE
    ZIMM, S
    CLEARY, SM
    LUCAS, WE
    WEISS, RJ
    MARKMAN, M
    ANDREWS, PA
    SCHIEFER, MA
    KIM, S
    HORTON, C
    HOWELL, SB
    CANCER RESEARCH, 1987, 47 (06) : 1712 - 1716
  • [8] PHASE-I AND PHARMACOKINETIC STUDY OF INTRAPERITONEAL THIOTEPA IN PATIENTS WITH OVARIAN-CANCER
    LEWIS, C
    LAWSON, N
    RANKIN, EM
    MORRISON, G
    MACLEAN, AB
    CORDINER, J
    CASSIDY, J
    KERR, DJ
    KAYE, SB
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (04) : 283 - 287
  • [9] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF TAXOL
    WIERNIK, PH
    SCHWARTZ, EL
    STRAUMAN, JJ
    DUTCHER, JP
    LIPTON, RB
    PAIETTA, E
    CANCER RESEARCH, 1987, 47 (09) : 2486 - 2493
  • [10] A PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THE ORAL AND THE ORAL INTRAVENOUS ADMINISTRATION OF MENOGARIL
    WEISS, GR
    BROWN, TD
    KUHN, JG
    VONHOFF, DD
    EARHART, RH
    ADAMS, WJ
    BREWER, JE
    HOSLEY, JD
    KASUNIC, DA
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (01) : 17 - 27
12345